Dexamethasone 24 mg/mL Injectable, 1 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St....
FDA Drug Recall #D-1395-2015 — Class II — June 15, 2015
Recall Summary
| Recall Number | D-1395-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 15, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Liberty Drug & Surgical |
| Location | Chatham, NJ |
| Product Type | Drugs |
| Quantity | 22 vials |
Product Description
Dexamethasone 24 mg/mL Injectable, 1 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.
Reason for Recall
Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.
Distribution Pattern
Physicians, Medical Facilities, and Prescription Specific Patients in NJ and NY
Lot / Code Information
Lot #: 05012015@1, Exp 06/15/15; 06022015@14, Exp 07/17/15; 06112015@10, Exp 07/26/15
Other Recalls from Liberty Drug & Surgical
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1387-2015 | Class II | Vancomycin 25 mg/mL Opthalmic Solution, package... | Jun 15, 2015 |
| D-1402-2015 | Class II | Hydroxocobalamin (Preserved) 1,000 mcg/mL Injec... | Jun 15, 2015 |
| D-1399-2015 | Class II | Methadone 10 mg/mL Injection, 10 mL vial, Rx on... | Jun 15, 2015 |
| D-1398-2015 | Class II | Phenol 6% Injectable, 30 mL vial, Rx only, Libe... | Jun 15, 2015 |
| D-1392-2015 | Class II | Hydroxocobalamin (Preserved) 10,000 mcg/mL Inje... | Jun 15, 2015 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.